 LOS ANGELES--BUSINESS WIRE--Second Sight Medical Products, Inc. NASDAQ: EYES the Company or Second Sight, a leading developer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today announced two-year results of its Early Feasibility Study Study of the Orion Visual Cortical Prosthesis Orion. The Study is a single arm six subject study at UCLA and Baylor College of Medicine. The Study was paused due 